Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 2024.Powered by Capital Market - Live News

Net profit of Bliss GVS Pharma declined 1.18% to Rs 27.61 crore in the quarter ended December 2023 as against Rs 27.94 crore during the previous quarter ended December 2022. Sales declined 2.43% to Rs 200.72 crore in the quarter ended December 2023 as against Rs 205.72 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales200.72205.72 -2 OPM %21.7723.18 - PBDT47.0052.07 -10 PBT40.0447.43 -16 NP27.6127.94 -1 Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 23 January 2024.Powered by Capital Market - Live News

Net profit of Bliss GVS Pharma rose 205.49% to Rs 42.31 crore in the quarter ended September 2023 as against Rs 13.85 crore during the previous quarter ended September 2022. Sales rose 22.88% to Rs 211.88 crore in the quarter ended September 2023 as against Rs 172.43 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales211.88172.43 23 OPM %25.6614.24 - PBDT65.5224.79 164 PBT59.1320.19 193 NP42.3113.85 205 Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 1 November 2023.Powered by Capital Market - Live News